Hybrid nanosystems based on natural polymers as protein carriers for respiratory delivery: Stability and toxicological evaluation

Carbohydrate Polymers

Volumn 123, Issue , 2015, Pages 369-380

  Rodrigues, Susana ^a   Cordeiro, Clara ^a,b   Seijo, Begoña ^c   Remuñán López, Carmen ^c   Grenha, Ana ^a  

^a UNIVERSITY OF ALGARVE   (Portugal)

^b UNIVERSITY OF LISBON   (Portugal)

^c UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

Author keywords

Biocompatibility; Microencapsulation; Nanoparticles; Nasal delivery Protein delivery; Pulmonary delivery

Indexed keywords

BIOCOMPATIBILITY; CELL CULTURE; MAMMALS; MICROENCAPSULATION; PROTEINS;

BOVINE SERUM ALBUMINS; HYBRID NANOSYSTEM; INFLAMMATORY RESPONSE; PROTEIN DELIVERY; PULMONARY DELIVERY; TOXICOLOGICAL EVALUATION; TRANSEPITHELIAL ELECTRICAL RESISTANCES; TRIPOLYPHOSPHATES;

NANOPARTICLES;

BOVINAE;

BIOMATERIAL; BOVINE SERUM ALBUMIN; CARRAGEENAN; CHITOSAN; CRYOPROTECTIVE AGENT; DRUG CARRIER; LYSOZYME; MONOSACCHARIDE; NANOPARTICLE; POLYMER; POLYPHOSPHATE; TRIPHOSPHORIC ACID;

CELL LINE; CELL SURVIVAL; CHEMISTRY; DRUG EFFECTS; DRUG FORMULATION; FREEZE DRYING; HUMAN; METABOLISM; SYNTHESIS;

BIOCOMPATIBLE MATERIALS; CARRAGEENAN; CELL LINE; CELL SURVIVAL; CHITOSAN; CRYOPROTECTIVE AGENTS; DRUG CARRIERS; DRUG COMPOUNDING; FREEZE DRYING; HUMANS; MONOSACCHARIDES; MURAMIDASE; NANOPARTICLES; POLYMERS; POLYPHOSPHATES; SERUM ALBUMIN, BOVINE;

EID: 84923166612     PISSN: 01448617     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.carbpol.2015.01.048     Document Type: Article

References (82)

1. W. Abdelwahed, G. Degobert, S. Stainmesse, and H. Fessi Freeze-drying of nanoparticles: Formulation, process and storage considerations Advanced Drug Delivery Reviews 58 15 2006 1688 1713
2. K.L. Aillon, Y. Xie, N. El-Gendy, C.J. Berkland, and M.L. Forrest Effects of nanomaterial physicochemical properties on in vivo toxicity Advanced Drug Delivery Reviews 61 6 2009 457 466
3. S. Al-Qadi, A. Grenha, D. Carrión-Recio, B. Seijo, and C. Remuñán-López Microencapsulated chitosan nanoparticles for pulmonary protein delivery: In vivo evaluation of insulin-loaded formulations Journal of Controlled Release 157 2012 383 390
4. E. Alfaro-Moreno, V. Torres, J. Miranda, L. Martínez, C. García-Cuellar, and T.S. Nawrot Induction of IL-6 and inhibition of IL-8 secretion in the human airway cell line Calu-3 by urban particulate matter collected with a modified method of PM sampling Environmental Research 109 5 2009 528 535
5. I. Behrens, A.I. Pena, M.J. Alonso, and T. Kissel Comparative uptake studies of bioadhesive and non-bioadhesive nanoparticles in human intestinal cell lines and rats: The effect of mucus on particle adsorption and transport Pharmaceutical Research 19 2002 1185 1193
6. J. Beirowski, S. Inghelbrecht, A. Arien, and H. Gieseler Freeze drying of nanosuspensions, 2: The role of the critical formulation temperature on stability of drug nanosuspensions and its practical implication on process design Journal of Pharmaceutical Sciences 100 2011 4471 4481
7. J. Beirowski, S. Inghelbrecht, A. Arien, and H. Gieseler Freeze drying of nanosuspensions, Part 3: Investigation of factors compromising storage stability of highly concentrated drug nanosuspensions Journal of Pharmaceutical Sciences 101 2012 354 362
8. A. Bernkop-Schnürch, A. Weithaler, K. Albrecht, and A. Greimel Thiomers: Preparation and in vitro evaluation of a mucoadhesive nanoparticulate drug delivery system International Journal of Pharmaceutics 317 1 2006 76 81
9. M. Bogataj, T. Vovk, M. Kerec, A. Dimnik, I. Grabnar, and A. Mrhar The correlation between zeta potential and mucoadhesion strength on pig vesical mucosa Biological and Pharmaceutical Bulletin 26 5 2003 743 746
10. C. Bosquillon, C. Lombry, V. Préat, and R. Vanbever Influence of formulation excipients and physical characteristics of inhalation dry powders on their aerosolization performance Journal of Controlled Release 70 3 2001 329 339
11. S. Caban, Y. Capan, P. Couvreur, and T. Dalkara Preparation and characterization of biocompatible chitosan nanoparticles for targeted brain delivery of peptides S. Skaper, Neurotrophic Factors 2012 Humana Press London 321 332
12. J. Carmichael, W. DeGraff, A. Gazdar, J. Minna, and J. Mitchell Evaluation of a tetrazolium-based semiautomated colorimetric assay: Assessment of chemosensitivity testing Cancer Research 47 1987 936 942
13. E.L.S. Carvalho, A. Grenha, C. Remunan-Lopez, M.J. Alonso, and B. Seijo Mucosal delivery of liposome-chitosan nanoparticle complexes Methods in Enzymology Liposomes, Pt G 465 2009 289 312
14. F. Carvalho, M. Bruschi, R. Evangelista, and M. Gremião Mucoadhesive drug delivery systems Brazilian Journal of Pharmaceutical Sciences 46 1 2010 1 17
15. L. Casettari, D. Vllasaliu, G. Mantovani, S.M. Howdle, S. Stolnik, and L. Illum Effect of PEGylation on the toxicity and permeability enhancement of chitosan Biomacromolecules 11 11 2010 2854 2865
16. M. Chacón, J. Molpeceres, L. Berges, M. Guzmán, and M.R. Aberturas Stability and freeze-drying of cyclosporine loaded poly(d,l lactide-glycolide) carriers European Journal of Pharmaceutical Sciences 8 2 1999 99 107
17. ® CCL-185™).
18. M. de la Fuente, B. Seijo, and M.J. Alonso Novel hyaluronan-based nanocarriers for transmucosal delivery of macromolecules Macromolecular Bioscience 8 5 2008 441 450
19. M.P. Desai, V. Labhasetwar, G.L. Amidon, and R.J. Levy Gastrointestinal uptake of biodegradable microparticles: Effect of particle size Pharmaceutical Research 13 12 1996 1838 1845
20. M. Dionísio, C. Cordeiro, C. Remuñán-López, B. Seijo, A. Rosa da Costa, and A. Grenha Pullulan-based nanoparticles as carriers for transmucosal protein delivery European Journal of Pharmaceutical Sciences 50 2013 102 113
21. C.Y. Dombu, and D. Betbeder Airway delivery of peptides and proteins using nanoparticles Biomaterials 34 2 2013 516 525
22. H. Du, X. Cai, and G. Zhai Advances in the targeting molecules modified chitosan-based nanoformulations Current Drug Targets 14 9 2014 1034 1052
23. I. El-Gibaly Development and in vitro evaluation of novel floating chitosan microcapsules for oral use: Comparison with non-floating chitosan microspheres International Journal of Pharmaceutics 249 1-2 2002 7 21
24. B.I. Florea, M. Thanou, H.E. Junginger, and G. Borchard Enhancement of bronchial octreotide absorption by chitosan and N-trimethyl chitosan shows linear in vitro/in vivo correlation Journal of Controlled Release 110 2 2006 353 361
25. B. Forbes, and C. Ehrhardt Human respiratory epithelial cell culture for drug delivery applications European Journal of Pharmaceutics and Biopharmaceutics 60 2 2005 193 205
26. K.A. Foster, M.L. Avery, M. Yazdanian, and K.L. Audus Characterization of the Calu-3 cell line as a tool to screen pulmonary drug delivery International Journal of Pharmaceutics 208 1-2 2000 1 11
27. K.A. Foster, M. Yazdanian, and K.L. Audus Microparticulate uptake mechanisms of in-vitro cell culture models of the respiratory epithelium Journal of Pharmacy and Pharmacology 53 1 2001 57 66
28. P. Freixeiro, E. Diéguez-Casal, L. Costoya, B. Seijo, C.M. Ferreirós, and M.T. Criado Study of the stability of proteoliposomes as vehicles for vaccines against Neisseria meningitidis based on recombinant porin complexes International Journal of Pharmaceutics 443 1-2 2013 1 8
29. R. Gaspar, and R. Duncan Polymeric carriers: Preclinical safety and the regulatory implications for design and development of polymer therapeutics Advanced Drug Delivery Reviews 61 13 2009 1220 1231
30. F.M. Goycoolea, G. Lollo, C. Remunan-Lopez, F. Quaglia, and M.J. Alonso Chitosan-alginate blended nanoparticles as carriers for the transmucosal delivery of macromolecules Biomacromolecules 10 7 2009 1736 1743
31. C. Grainger, L. Greenwell, D. Lockley, G. Martin, and B. Forbes Culture of Calu-3 cells at the air interface provides a representative model of the airway epithelial barrier Pharmaceutical Research 23 7 2006 1482 1490
32. C.I. Grainger, L.L. Greenwell, G.P. Martin, and B. Forbes The permeability of large molecular weight solutes following particle delivery to air-interfaced cells that model the respiratory mucosa European Journal of Pharmaceutics and Biopharmaceutics 71 2 2009 318 324
33. A. Grenha Chitosan nanoparticles: A survey of preparation methods Journal of Drug Targeting 20 4 2012 291 300
34. A. Grenha, M.E. Gomes, M. Rodrigues, V.E. Santo, J.F. Mano, and N.M. Neves Development of new chitosan/carrageenan nanoparticles for drug delivery applications Journal of Biomedical Materials Research A 92A 4 2010 1265 1272
35. A. Grenha, C.I. Grainger, L.A. Dailey, B. Seijo, G.P. Martin, and C. Remuñán-López Chitosan nanoparticles are compatible with respiratory epithelial cells in vitro European Journal of Pharmaceutical Sciences 31 2 2007 73 84
36. A. Grenha, B. Seijo, and C. Remuñán-López Microencapsulated chitosan nanoparticles for lung protein delivery European Journal of Pharmaceutical Sciences 25 2005 427 437
37. H. Gupta, and A. Sharma Recent trends in protein and peptide drug delivery systems Asian Journal of Pharmaceutics 3 2009 69 75
38. S. Hirsjärvi, L. Peltonen, and J. Hirvonen Effect of sugars, surfactant, and tangential flow filtration on the freeze-drying of poly(lactic acid) nanoparticles AAPS PharmSciTech 10 2 2009 488 494
39. M. Hoppentocht, P. Hagedoorn, H.W. Frijlink, and A.H. de Boer Developments and strategies for inhaled antibiotic drugs in tuberculosis therapy: A critical evaluation European Journal of Pharmaceutics and Biopharmaceutics 86 1 2014 23 30
40. M. Huang, E. Khor, and L.-Y. Lim Uptake and cytotoxicity of chitosan molecules and nanoparticles: Effects of molecular weight and degree of deacetylation Pharmaceutical Research 21 2 2004 344 353
41. ISO Biological evaluation of medical devices Part 5: Tests for in vitro cytotoxicity I. O. f. Standardization 10993-5 2009
42. P. Jani, G. Halbert, J. Langridge, and A. Florence Nanoparticle uptake by the rat gastrointestinal mucosa: Quantitation and particle size dependency Journal of Pharmacy and Pharmacology 42 12 1990 821 826
43. T.D. Klingberg, M.H. Pedersen, A. Cencic, and B.B. Budde Application of measurements of transepithelial electrical resistance of intestinal epithelial cell monolayers to evaluate probiotic activity Applied and Environmental Microbiology 71 11 2005 7528 7530
44. M. Konstan, P. Chen, J. Sherman, M. Thomassen, R. Woodm, and T. Boat Human lung lysozyme: Sources and properties American Reviews of Respiratory Disease 123 1981 120 124
45. G. Kumar, N. Shafiq, and S. Malhotra Drug-loaded PLGA nanoparticles for oral administration: Fundamental issues and challenges ahead Critical Reviews in Therapeutic Drug Carrier Systems 29 2 2012 149 182
46. N. Labiris, A. Holbrook, H. Chrystyn, S. Macleod, and M. Newhouse Dry powder versus intravenous and nebulized gentamicin in cystic fibrosis and bronchiectasis American Journal of Respiratory and Critical Care Medicine 160 1999 1711 1716
47. C.-M. Lehr, J.A. Bouwstra, E.H. Schacht, and H.E. Junginger In vitro evaluation of mucoadhesive properties of chitosan and some other natural polymers International Journal of Pharmaceutics 78 1992 43 48
48. C. Lewis, and J.D. McGee The macrophage 1992 IRL Press Oxford
49. S. Li, T. Patapoff, D. Overcashier, C. Hsu, T. Nguyen, and R. Borchardt Effects of reducing sugars on the chemical stability of human relaxin in the lyophilized state Journal of Pharmaceutical Sciences 85 8 1996 873 877
50. Y.-Z. Li, X. Sun, T. Gong, J. Liu, J. Zuo, and Z.-R. Zhang Inhalable microparticles as carriers for pulmonary delivery of thymopentin-loaded solid lipid nanoparticles Pharmaceutical Research 27 9 2010 1977 1986
51. C.K. Lim, N.S. Yaacob, Z. Ismail, and A.S. Halim In vitro biocompatibility of chitosan porous skin regenerating templates (PSRTs) using primary human skin keratinocytes Toxicology in Vitro 24 3 2010 721 727
52. P. Malafaya, G. Silva, and R. Reis Natural-origin polymers as carriers and scaffolds for biomolecules and cell delivery in tissue engineering application Advanced Drug Delivery Reviews 59 2007 207 233
53. E. Marttin, N.G.M. Schipper, J.C. Verhoef, and F.W.H.M. Merkus Nasal mucociliary clearance as a factor in nasal drug delivery Advanced Drug Delivery Reviews 29 1-2 1998 13 38
54. K. Matter, and M. Balda Functional analysis of tight junctions Methods 30 2003 228 234
55. J. McCarthy, I. Inkielewicz-Stępniak, J.J. Corbalan, and M.W. Radomski Mechanisms of toxicity of amorphous silica nanoparticles on human lung submucosal cells in vitro: Protective effects of fisetin Chemical Research in Toxicology 25 10 2012 2227 2235
56. S. Mura, H. Hillaireau, J. Nicolas, B. Le Droumaguet, C. Gueutin, and S. Zanna Influence of surface charge on the potential toxicity of PLGA nanoparticles towards Calu-3 cells International Journal of Nanomedicine 6 2011 2591 2605
57. R. Muzzarelli Human enzymatic activities related to the therapeutic administration of chitin derivatives Cellular and Molecular Life Sciences 53 1997 131 140
58. K. Nahar, N. Gupta, R. Gauvin, S. Absar, B. Patel, and V. Gupta In vitro, in vivo and ex vivo models for studying particle deposition and drug absorption of inhaled pharmaceuticals European Journal of Pharmaceutical Sciences 49 5 2013 805 818
59. G. Oberdörster, E. Oberdörster, and J. Oberdörster Nanotoxicology: An emerging discipline evolving from studies of ultrafine particles Environmental and Health Perspectives 113 2005 823 839
60. A. Oliveira, A. Silva, D. Bitoque, G. Silva, and A. Rosa da Costa Transfection efficiency of chitosan and thiolated chitosan in retinal pigment epithelium cells: A comparative study Journal of Pharmacy and Bioallied Sciences 5 2013 111 118
61. F. Oyarzun-Ampuero, J. Brea, M. Loza, D. Torres, and M.J. Alonso Chitosan-hyaluronic acid nanoparticles loaded with heparin for the treatment of asthma International Journal of Pharmaceutics 381 2009 122 129
62. C. Pinto Reis, R. Neufeld, A. Ribeiro, and F. Veiga Nanoencapsulation II. Biomedical applications and current status of peptide and protein nanoparticulate delivery systems Nanomedicine: Nanotechnology, Biology, and Medicine 2 2006 53 65
63. A. Portero, C. Remuñán-López, and H.M. Nielsen The potential of chitosan in enhancing peptide and protein absorption across the TR146 cell culture model - An in vitro model of the buccal epithelium Pharmaceutical Research 19 2 2002 169 174
64. P.S. Pourshahab, K. Gilani, E. Moazeni, H. Eslahi, M.R. Fazeli, and H. Jamalifar Preparation and characterization of spray dried inhalable powders containing chitosan nanoparticles for pulmonary delivery of isoniazid Journal of Microencapsulation 28 7 2011 605 613
65. S. Rodrigues, M. Dionísio, C. Remuñán-López, and A. Grenha Biocompatibility of chitosan carriers with application in drug delivery Journal of Functional Biomaterials 3 2012 615 641
66. S. Rodrigues, A. Rosa da Costa, and A. Grenha Chitosan/carrageenan nanoparticles: Effect of cross-linking with tripolyphosphate and charge ratios Carbohydrate Polymers 89 2012 282 289
67. P. Rogueda, and D. Traini The nanoscale in pulmonary delivery. Part 1: Deposition, fate, toxicology and effects Expert Opinion on Drug Delivery 4 6 2007 595 606
68. M. Sameti, G. Bohr, M.N.V. Ravi Kumar, C. Kneuer, U. Bakowsky, and M. Nacken Stabilisation by freeze-drying of cationically modified silica nanoparticles for gene delivery International Journal of Pharmaceutics 266 1-2 2003 51 60
69. G. Sandri, M. Bonferoni, S. Rossi, F. Ferrari, C. Boselli, and C. Caramella Insulin-loaded nanoparticles based on N-trimethyl chitosan: In vitro (Caco-2 model) and ex vivo (excised rat jejunum, duodenum, and ileum) evaluation of penetration enhancement properties AAPS PharmSciTech 11 1 2010 362 371
70. R. Scherließ The MTT assay as tool to evaluate and compare excipient toxicity in vitro on respiratory epithelial cells International Journal of Pharmaceutics 411 1-2 2011 98 105
71. J. Smith, E. Wood, and M. Dornish Effect of chitosan on epithelial cell tight junctions Pharmaceutical Research 21 1 2004 43 49
72. D.I. Sonnier, S.R. Bailey, T.A. Pritts, and A.B. Lentsch TNF-α induced vectorial secretion of IL-8 corresponds to development of transepithelial electrical resistance in Caco-2 cells Gastroenterology 140 5 2011 S S1044
73. J.C. Sung, B.L. Pulliam, and D.A. Edwards Nanoparticles for drug delivery to the lungs Trends in Biotechnology 25 12 2007 563 570
74. M. Umrethia, V.L. Kett, G.P. Andrews, R.K. Malcolm, and A.D. Woolfson Selection of an analytical method for evaluating bovine serum albumin concentrations in pharmaceutical polymeric formulations Journal of Pharmaceutical and Biomedical Analysis 51 5 2010 1175 1179
75. C. Vauthier, and K. Bouchemal Methods for the preparation and manufacture of polymeric nanoparticles Pharmaceutical Research 26 5 2009 1025 1058
76. A. Vila, A. Sánchez, M. Tobío, P. Calvo, and M.J. Alonso Design of biodegradable particles for protein delivery Journal of Controlled Release 78 1-3 2002 15 24
77. W. Wang Lyophilization and development of solid protein pharmaceuticals International Journal of Pharmaceutics 203 1-2 2000 1 60
78. D.F. Williams On the mechanisms of biocompatibility Biomaterials 29 20 2008 2941 2953
79. H. Winton, H. Wan, M. Cannell, D. Gruenert, P. Thompson, and D. Garrod Cell lines of pulmonary and non-pulmonary origin as tools to study the effects of house dust mite proteinases on the regulation of epithelial permeability Clinical & Experimental Allergy 28 10 1998 1273 1285
80. L. Wu, J. Zhang, and W. Watanabe Physical and chemical stability of drug nanoparticles Advanced Drug Delivery Reviews 63 6 2011 456 469
81. Y. Zhu, A. Chidekel, and T. Shaffer Cultured human airway epithelial cells (Calu-3): A model of human respiratory function, structure, and inflammatory responses Critical Care Research and Practice 2010 2010 1 8
82. G.K. Zorzi, J.E. Párraga, B. Seijo, and A. Sánchez Hybrid nanoparticle design based on cationized gelatin and the polyanions dextran sulfate and chondroitin sulfate for ocular gene therapy Macromolecular Bioscience 11 7 2011 905 913